Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women

Vilma Guimaraes, Rafael Guimaraes, Lucas Brandao, Maria Fernanda Piffer Tomasi Baldez da Silva, Michele Milanese, Ludovica Segat, Henrique Castelletti, Danielly Bruneska, Josè Luiz de Lima Filho, Antonio Carlos de Freitas, Luiz Claudio Arraes, Cintia Rocha, Sergio Crovella

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We studied the association between high-risk human papillomavirus (HPV) infection and MBL2 functional polymorphisms in a group of 180 high-risk HPV-infected women and 180 healthy control subjects. The most frequent high-risk HPV genotypes were 16 (47.2%), 31 (11.7%), 33 (5%), and 18 (2.2%), respectively. Of the 180 HPV-infected women, 99 presented with uterine cervical cancer and 81 did not. No differences in MBL2 genotype or in allelic or haplotype frequencies were found between HPV patients who developed cervical uterine cancer and those who did not. When considering combined genotypes grouped according to MBL production (designated as high, low, and deficient producers), we detected a significant difference between healthy controls and high-risk HPV-positive patients, the latter group showing increased frequencies of deficient-producer genotypes (14.4% vs 9.4% in the healthy control group, corrected p = 0.04). In conclusion, a correlation between MBL2 polymorphisms and high-risk HPV infection was found in this study.

Original languageEnglish
Pages (from-to)273-278
Number of pages6
JournalHuman Immunology
Volume69
Issue number4-5
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Papillomavirus Infections
Genes
Genotype
Uterine Cervical Neoplasms
Haplotypes
Healthy Volunteers
Control Groups

Keywords

  • Brazilian women
  • Cervical uterine cancer
  • Genetic polymorphisms
  • High- and low-risk HPV genotypes
  • Innate immunity
  • MBL2

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women. / Guimaraes, Vilma; Guimaraes, Rafael; Brandao, Lucas; Baldez da Silva, Maria Fernanda Piffer Tomasi; Milanese, Michele; Segat, Ludovica; Castelletti, Henrique; Bruneska, Danielly; de Lima Filho, Josè Luiz; de Freitas, Antonio Carlos; Arraes, Luiz Claudio; Rocha, Cintia; Crovella, Sergio.

In: Human Immunology, Vol. 69, No. 4-5, 04.2008, p. 273-278.

Research output: Contribution to journalArticle

Guimaraes, V, Guimaraes, R, Brandao, L, Baldez da Silva, MFPT, Milanese, M, Segat, L, Castelletti, H, Bruneska, D, de Lima Filho, JL, de Freitas, AC, Arraes, LC, Rocha, C & Crovella, S 2008, 'Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women', Human Immunology, vol. 69, no. 4-5, pp. 273-278. https://doi.org/10.1016/j.humimm.2008.03.002
Guimaraes, Vilma ; Guimaraes, Rafael ; Brandao, Lucas ; Baldez da Silva, Maria Fernanda Piffer Tomasi ; Milanese, Michele ; Segat, Ludovica ; Castelletti, Henrique ; Bruneska, Danielly ; de Lima Filho, Josè Luiz ; de Freitas, Antonio Carlos ; Arraes, Luiz Claudio ; Rocha, Cintia ; Crovella, Sergio. / Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women. In: Human Immunology. 2008 ; Vol. 69, No. 4-5. pp. 273-278.
@article{d567d44cdf654822948319fb3a131175,
title = "Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women",
abstract = "We studied the association between high-risk human papillomavirus (HPV) infection and MBL2 functional polymorphisms in a group of 180 high-risk HPV-infected women and 180 healthy control subjects. The most frequent high-risk HPV genotypes were 16 (47.2{\%}), 31 (11.7{\%}), 33 (5{\%}), and 18 (2.2{\%}), respectively. Of the 180 HPV-infected women, 99 presented with uterine cervical cancer and 81 did not. No differences in MBL2 genotype or in allelic or haplotype frequencies were found between HPV patients who developed cervical uterine cancer and those who did not. When considering combined genotypes grouped according to MBL production (designated as high, low, and deficient producers), we detected a significant difference between healthy controls and high-risk HPV-positive patients, the latter group showing increased frequencies of deficient-producer genotypes (14.4{\%} vs 9.4{\%} in the healthy control group, corrected p = 0.04). In conclusion, a correlation between MBL2 polymorphisms and high-risk HPV infection was found in this study.",
keywords = "Brazilian women, Cervical uterine cancer, Genetic polymorphisms, High- and low-risk HPV genotypes, Innate immunity, MBL2",
author = "Vilma Guimaraes and Rafael Guimaraes and Lucas Brandao and {Baldez da Silva}, {Maria Fernanda Piffer Tomasi} and Michele Milanese and Ludovica Segat and Henrique Castelletti and Danielly Bruneska and {de Lima Filho}, {Jos{\`e} Luiz} and {de Freitas}, {Antonio Carlos} and Arraes, {Luiz Claudio} and Cintia Rocha and Sergio Crovella",
year = "2008",
month = "4",
doi = "10.1016/j.humimm.2008.03.002",
language = "English",
volume = "69",
pages = "273--278",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "4-5",

}

TY - JOUR

T1 - Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women

AU - Guimaraes, Vilma

AU - Guimaraes, Rafael

AU - Brandao, Lucas

AU - Baldez da Silva, Maria Fernanda Piffer Tomasi

AU - Milanese, Michele

AU - Segat, Ludovica

AU - Castelletti, Henrique

AU - Bruneska, Danielly

AU - de Lima Filho, Josè Luiz

AU - de Freitas, Antonio Carlos

AU - Arraes, Luiz Claudio

AU - Rocha, Cintia

AU - Crovella, Sergio

PY - 2008/4

Y1 - 2008/4

N2 - We studied the association between high-risk human papillomavirus (HPV) infection and MBL2 functional polymorphisms in a group of 180 high-risk HPV-infected women and 180 healthy control subjects. The most frequent high-risk HPV genotypes were 16 (47.2%), 31 (11.7%), 33 (5%), and 18 (2.2%), respectively. Of the 180 HPV-infected women, 99 presented with uterine cervical cancer and 81 did not. No differences in MBL2 genotype or in allelic or haplotype frequencies were found between HPV patients who developed cervical uterine cancer and those who did not. When considering combined genotypes grouped according to MBL production (designated as high, low, and deficient producers), we detected a significant difference between healthy controls and high-risk HPV-positive patients, the latter group showing increased frequencies of deficient-producer genotypes (14.4% vs 9.4% in the healthy control group, corrected p = 0.04). In conclusion, a correlation between MBL2 polymorphisms and high-risk HPV infection was found in this study.

AB - We studied the association between high-risk human papillomavirus (HPV) infection and MBL2 functional polymorphisms in a group of 180 high-risk HPV-infected women and 180 healthy control subjects. The most frequent high-risk HPV genotypes were 16 (47.2%), 31 (11.7%), 33 (5%), and 18 (2.2%), respectively. Of the 180 HPV-infected women, 99 presented with uterine cervical cancer and 81 did not. No differences in MBL2 genotype or in allelic or haplotype frequencies were found between HPV patients who developed cervical uterine cancer and those who did not. When considering combined genotypes grouped according to MBL production (designated as high, low, and deficient producers), we detected a significant difference between healthy controls and high-risk HPV-positive patients, the latter group showing increased frequencies of deficient-producer genotypes (14.4% vs 9.4% in the healthy control group, corrected p = 0.04). In conclusion, a correlation between MBL2 polymorphisms and high-risk HPV infection was found in this study.

KW - Brazilian women

KW - Cervical uterine cancer

KW - Genetic polymorphisms

KW - High- and low-risk HPV genotypes

KW - Innate immunity

KW - MBL2

UR - http://www.scopus.com/inward/record.url?scp=43449119493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43449119493&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2008.03.002

DO - 10.1016/j.humimm.2008.03.002

M3 - Article

C2 - 18486762

AN - SCOPUS:43449119493

VL - 69

SP - 273

EP - 278

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 4-5

ER -